drugset / Trial / NCT01374126
Azithromycin Combination Therapy for the Treatment of Severe Malaria
Phase 2
Completed
75 enrolled
Medical University of Vienna
International Centre for Diarrhoeal Disease Research, Bangladesh · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
A randomized controlled trial to assess the safety and efficacy of azithromycin combination therapy for use in severe malaria. This pilot trial will be conducted in uncomplicated malaria patients in southeastern Bangladesh.
Timeline
- Start
- 2011-07
- Primary completion
- 2012-11
- Completion
- 2012-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Artesunate | Small molecule | — | — |
| Subject | Azithromycin | Small molecule | — | — |